Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

London Branch Of Unified Patent Court To Boost UK's Standing In Pharma Litigation

This article was originally published in The Pink Sheet Daily

Executive Summary

Eight of the needed 13 EU member states have ratified agreement for a single European patent system, and the UK's approval is expected early next year.

You may also be interested in...



The Brexit Effect: What Would It Mean For Europe's Future Patent System?

UK referendum on whether to remain in EU will take place around the time that the Unified Patent Court is expected to launch.

Drug Makers Relieved As Europe's Unitary Patent Gets Predictable Boost

The Advocate General of the Court of Justice of the European Union has dismissed Spain’s second challenge to the unitary patent, offering more legal certainty for drug manufacturers and pointing the way towards reduced litigation costs.

Patent Express Lanes Coming To Europe, But Tolls Remain A Question

Europe is on the brink of creating a unified patent court and unitary patent, which will cut litigation and application costs, while giving a boost to legal predictability.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS078819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel